Inhibitory effect of cantharidin on proliferation of A549 cells

Chinese Journal of Cancer Research

Volumn 19, Issue 4, 2007, Pages 283-286

  Wang, Xiao Hua ^a   Yin, Yuan Qin ^a   Sui, Cheng Guang ^a   Meng, Fan Dong ^a   Ma, Ping ^a   Jiang, You Hong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cantharidin(CTD); Human lung cancer cells A549; Inhibition

Indexed keywords

CANTHARIDIN; LIPOCORTIN 5;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG SENSITIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG CANCER;

EID: 37549002069     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-007-0283-2     Document Type: Article

References (10)

1. Jiang LH, Wang MY. Research progress on Mylabris[J]. Herald Med 2004; 23: 385-6.
2. Jin W, Wang YW, Zhou ZX, et al. The effects of canthacidiu on HL-60 and QGY7703 cell line[J]. Acta Chin Med Pharmacal 2001; 29: 42-3.
3. Li B, Ling CQ. Advances in basic and clinical studies of norcantharidin[J]. Chin Tradit Herbs Drugs(in Chin) 2002; 33: 184-5.
4. Li FZ, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by Survivin[J]. Nature 1998; 396: 580-4.
5. Sun ZX, Wei YL, Zhao TD, et al. the studies of CTD and Norcantharidin induced HEL; human erythroleukemia K562 apoptosis[J]. J Anat(in Chin) 2000;31:56-60.
6. Sherr CJ. The pezcoler lecture: Cancer cell-cycles revisited[J]. Cancer Res 2000; 60: 3689-95.
7. Roberts JR, Allison DC, Donehower RC, et al. development of polyploidization in taxol resistant human leukemia cells in vivo[J]. Cancer Res 1990; 50: 710-6.
8. Kerr JF, winterford CM, Harmon BV. Apoptosis, its significance in cancer and cancer therapy[J]. Cancer 1994; 73: 3108.
9. Blagosklonny MV, Pardee AB. Exploiting cancer cell cycling for selective protection of normal cell[J]. Cancer Res 2001; 61: 4301-5.
10. Hartwell L, Kastsan MB. Cell cycle control and cancer[J]. Science 1994; 266: 1820-8.